G1 Therapeutics (GTHX) Insider Trading & Ownership

$7.15

0.00 (0.00%)

(As of 09/18/2024)

Current Insider Ownership Percentage: 6.11%
Number Of Insiders Buying (Last 12 Months): 0
Number Of Insiders Selling (Last 12 Months): 6
Amount Of Insider Selling (Last 12 Months): $442,014.23

Get GTHX Insider Trade Alerts

Want to know when executives and insiders are buying or selling G1 Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

GTHX Insider Buying and Selling by Quarter

Ad Weiss Ratings

Who are Nvidia’s New Silent Partners?

Nvidia knows it can’t stand still as AI continues to grow at an exponential rate. That’s why CEO Jensen Huang consistently has his company ahead of the curve when it comes to artificial intelligence. Nvidia’s added $2 trillion in market cap in 2024.

I call these Nvidia’s “Silent Partners.”

G1 Therapeutics Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
7/5/2024	Andrew Perry	Insider	Sell	1,337	$2.51	$3,355.87
7/5/2024	John E (Jack) Jr. Bailey	CEO	Sell	7,662	$2.51	$19,231.62
7/5/2024	John W V Umstead	CFO	Sell	527	$2.51	$1,322.77
7/5/2024	Terry L Murdock	COO	Sell	2,475	$2.51	$6,212.25
5/23/2024	Monica R Thomas	Insider	Sell	5,826	$4.27	$24,877.02
3/18/2024	John W V Umstead	CFO	Sell	6,547	$3.02	$19,771.94
The death of Nvidia? (Ad) Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming. So go here now to read my new report The Big AI Die-Up… while you still can.
2/12/2024	Rajesh Malik	Insider	Sell	28,600	$4.62	$132,132.00
1/4/2024	John W V Umstead	CFO	Sell	111	$2.94	$326.34
1/4/2024	Terry L Murdock	COO	Sell	721	$2.94	$2,119.74
1/3/2024	Rajesh Malik	Insider	Sell	3,019	$3.12	$9,419.28
1/2/2024	John E (Jack) Jr. Bailey	CEO	Sell	32,983	$3.27	$107,854.41
12/11/2023	Rajesh Malik	Insider	Sell	33,839	$3.41	$115,390.99

(Data available from 1/1/2013 forward)

GTHX Insider Trading Activity - Frequently Asked Questions

: The list of insiders at G1 Therapeutics includes Andrew Perry, James S Hanson, Jennifer K Moses, John E (Jack) Jr. Bailey, John W V Umstead, Mark A Velleca, Monica R Thomas, Rajesh Malik, and Terry L Murdock. Learn more on insiders at GTHX.
: 6.11% of G1 Therapeutics stock is owned by insiders. Learn more on GTHX's insider holdings.
: The following insiders have sold GTHX shares in the last 24 months: Andrew Perry ($8,801.22), Jennifer K Moses ($9,145.62), John E (Jack) Jr. Bailey ($321,058.73), John W V Umstead ($21,421.05), Mark A Velleca ($175,500.00), Monica R Thomas ($24,877.02), Rajesh Malik ($256,942.27), and Terry L Murdock ($15,610.33).
: Insiders have sold a total of 178,289 G1 Therapeutics shares in the last 24 months for a total of $833,356.24 sold.